HALOZYME THERAPEUTICS, INC. - Common Stock (HALO)

CUSIP: 40637H109

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class
Equity / Common Stock
Shares outstanding
123,650,000
Total 13F shares
106,009,210
Share change
+1,018,812
Total reported value
$1,279,976,335
Put/Call ratio
39%
Price per share
$12.08
Number of holders
161
Value change
+$17,256,778
Number of buys
71
Number of sells
73

Quarterly Holders Quick Answers

What is CUSIP 40637H109?
CUSIP 40637H109 identifies HALO - HALOZYME THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of HALO - HALOZYME THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Third Security, LLC
13F
Company
16%
19,305,403
$166,606,000 30 Jun 2016
13F
IRIDIAN ASSET MANAGEMENT LLC/CT
13F
Company
6.6%
8,191,274
$70,691,000 30 Jun 2016
13F
VANGUARD GROUP INC
13F
Company
6.2%
7,608,228
$65,658,000 30 Jun 2016
13F
BB BIOTECH AG
13F
Company
6%
7,379,832
$63,688,000 30 Jun 2016
13F
First Eagle Investment Management, LLC
13F
Company
5.7%
7,101,000
$61,282,000 30 Jun 2016
13F
FMR LLC
13F
Company
5.4%
6,691,247
$57,745,000 30 Jun 2016
13F
BlackRock Fund Advisors
13F
Company
3.5%
4,352,218
$37,560,000 30 Jun 2016
13F
STATE STREET CORP
13F
Company
2.9%
3,578,450
$30,880,000 30 Jun 2016
13F
JPMORGAN CHASE & CO
13F
Company
2.5%
3,082,218
$26,600,000 30 Jun 2016
13F
BlackRock Institutional Trust Company, N.A.
13F
Company
2.3%
2,845,357
$24,555,000 30 Jun 2016
13F
Bank of New York Mellon Corp
13F
Company
1.8%
2,279,701
$19,674,000 30 Jun 2016
13F
SNYDER CAPITAL MANAGEMENT L P
13F
Company
1.8%
2,267,787
$19,571,000 30 Jun 2016
13F
FRANKLIN RESOURCES INC
13F
Company
1.8%
2,216,929
$19,132,000 30 Jun 2016
13F
VOYA INVESTMENT MANAGEMENT LLC
13F
Company
1.5%
1,875,872
$16,189,000 30 Jun 2016
13F
BAKER BROS. ADVISORS LP
13F
Company
1.5%
1,838,057
$15,862,000 30 Jun 2016
13F
Invesco Ltd.
13F
Company
1.5%
1,793,534
$15,479,000 30 Jun 2016
13F
NORTHERN TRUST CORP
13F
Company
1.1%
1,311,180
$11,315,000 30 Jun 2016
13F
OppenheimerFunds, Inc.
13F
Company
0.81%
1,000,000
$8,630,000 30 Jun 2016
13F
PANAGORA ASSET MANAGEMENT INC
13F
Company
0.8%
984,723
$8,498,000 30 Jun 2016
13F
MSD Partners, L.P.
13F
Company
0.78%
965,000
$8,328,000 30 Jun 2016
13F
Lombard Odier Asset Management (USA) Corp
13F
Company
0.77%
948,803
$8,188,000 30 Jun 2016
13F
NORGES BANK
13F
Company
0.68%
837,637
$7,229,000 30 Jun 2016
13F
DEUTSCHE BANK AG\
13F
Company
0.68%
836,355
$7,216,000 30 Jun 2016
13F
SENZAR ASSET MANAGEMENT, LLC
13F
Company
0.64%
785,744
$6,780,971 30 Jun 2016
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.63%
776,138
$6,698,000 30 Jun 2016
13F
Fisher Asset Management, LLC
13F
Company
0.59%
725,011
$6,583,000 30 Jun 2016
13F
TEACHERS ADVISORS, LLC
13F
Company
0.58%
721,934
$6,230,000 30 Jun 2016
13F
CREDIT SUISSE AG/
13F
Company
0.41%
505,652
$4,364,000 30 Jun 2016
13F
QVT Financial LP
13F
Company
0.4%
500,449
$4,319,000 30 Jun 2016
13F
FRED ALGER MANAGEMENT, LLC
13F
Company
0.35%
432,289
$3,731,000 30 Jun 2016
13F
OXFORD ASSET MANAGEMENT LLP
13F
Company
0.34%
416,512
$3,594,000 30 Jun 2016
13F
BlackRock Investment Management, LLC
13F
Company
0.33%
406,054
$3,504,000 30 Jun 2016
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.31%
382,670
$3,302,000 30 Jun 2016
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.3%
373,642
$3,225,000 30 Jun 2016
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.3%
370,285
$3,196,000 30 Jun 2016
13F
MORGAN STANLEY
13F
Company
0.29%
355,607
$3,069,000 30 Jun 2016
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.28%
350,596
$3,026,000 30 Jun 2016
13F
TIAA CREF INVESTMENT MANAGEMENT LLC
13F
Company
0.28%
342,036
$2,952,000 30 Jun 2016
13F
Bellevue Group AG
13F
Company
0.26%
318,000
$2,744,000 30 Jun 2016
13F
MACQUARIE GROUP LTD
13F
Company
0.25%
304,800
$2,630,000 30 Jun 2016
13F
BROWN ADVISORY INC
13F
Company
0.22%
266,860
$2,303,000 30 Jun 2016
13F
GUGGENHEIM CAPITAL LLC
13F
Company
0.21%
253,563
$2,188,000 30 Jun 2016
13F
Rhenman & Partners Asset Management AB
13F
Company
0.2%
250,000
$2,158,000 30 Jun 2016
13F
BLACKROCK ADVISORS LLC
13F
Company
0.19%
229,716
$1,982,000 30 Jun 2016
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.18%
228,638
$1,973,000 30 Jun 2016
13F
SEI INVESTMENTS CO
13F
Company
0.18%
223,280
$1,927,000 30 Jun 2016
13F
UBS Group AG
13F
Company
0.18%
221,524
$1,911,000 30 Jun 2016
13F
Allianz Asset Management GmbH
13F
Company
0.17%
215,889
$1,863,000 30 Jun 2016
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.17%
212,100
$1,830,000 30 Jun 2016
13F
S.c.a. Candriam
13F
Individual
0.16%
202,000
$1,743,000 30 Jun 2016
13F

Institutional Holders of HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) as of Q3 2016

As of 30 Sep 2016, HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) was held by 161 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 106,009,210 shares. The largest 10 holders included Third Security, LLC, IRIDIAN ASSET MANAGEMENT LLC/CT, VANGUARD GROUP INC, FMR LLC, First Eagle Investment Management, LLC, BB BIOTECH AG, BlackRock Fund Advisors, STATE STREET CORP, BlackRock Institutional Trust Company, N.A., and JPMORGAN CHASE & CO. This page lists 161 institutional shareholders reporting positions in this security for the Q3 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2016 vs Q2 2016 Across Filers

Q2 2016 holders
159
Q3 2016 holders
161
Holder diff
2
Investor Q2 2016 Shares Q3 2016 Shares Share Diff Share Chg % Q2 2016 Value $ Q3 2016 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.